Vidalista Professional (a tadalafil‑based erectile dysfunction tablet), adverse effects are monitored and reported through pharmacovigilance systems by multiple parties — not just one single group. Here’s how this  Who Reports Adverse Effects Healthcare professionals Doctors, pharmacists, nurses, and other clinicians report suspected side effects they observe in patients. These reports help regulators and manufacturers track safety. Patients and consumers You or anyone taking the medication can report an adverse effect, even if it seems mild. This can be done through your doctor or directly to the manufacturer or national safety programme. Drug manufacturers The company that makes Vidalista Professional collects adverse event reports from doctors, patients, and other sources as part of ongoing safety monitoring. They submit these to regulatory authorities. National pharmacovigilance programmes In India, the Pharmacovigilance Programme of India (PvPI) collects reports of suspected side effects for all medicines, including tadalafil products like Vidalista Professional. These are forwarded to regulators to assess safety signals.